Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31872
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMAIA, Manuel Caitano
dc.contributor.authorHANSEN, Aaron
dc.contributor.authorALVES, Carolina
dc.contributor.authorSALAH, Samer
dc.date.accessioned2019-05-30T13:42:43Z
dc.date.available2019-05-30T13:42:43Z
dc.date.issued2019
dc.identifier.citationCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, v.135, p.76-84, 2019
dc.identifier.issn1040-8428
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31872
dc.description.abstractNon-urothelial (NU) histologies represent less than 10% of bladder cancers, with squamous cell carcinoma (SCC) being the most common subtype (approximately 5%). Bladder SCCs are subdivided into Schistosoma-related or non-Schistosoma-related tumors, with the latter being the most frequent subtype in the western world. Typically, these patients have been excluded or under-represented in clinical trials and thus little is known about treatment efficacy in bladder SCC. To address this paucity of data, extrapolation from urothelial carcinoma (UC) trials can be performed but this approach has inherent limitations. In the era of precision medicine, efforts to characterize the genomic and molecular profiles of bladder tumors may yield evidence to support new targets for effective therapies. We reviewed the available data on biomarkers of bladder SCC and provide suggestions on how these may influence therapeutic testing and clinical trials in the future.eng
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofCritical Reviews in Oncology Hematology
dc.rightsrestrictedAccesseng
dc.subjectBiomarkerseng
dc.subjectSquamouseng
dc.subjectBladdereng
dc.subjectNon-Bilharzialeng
dc.subjectNon-Schistosomiasiseng
dc.subject.othermetastatic urothelial carcinomaeng
dc.subject.othergrowth-factor receptoreng
dc.subject.otherradical cystectomyeng
dc.subject.otherluminal subtypeseng
dc.subject.otherrandomized-trialeng
dc.subject.otherprognostic valueeng
dc.subject.otherdouble-blindeng
dc.subject.othersingle-armeng
dc.subject.otherphase-ieng
dc.subject.othercancereng
dc.titleBiomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A revieweng
dc.typearticleeng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.identifier.doi10.1016/j.critrevonc.2019.01.008
dc.identifier.pmid30819449
dc.subject.wosOncologyeng
dc.subject.wosHematologyeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalMAIA, Manuel Caitano:Ctr Oncol Parana, Med Oncol, Rod BR 277,1437, BR-82305100 Curitiba, Parana, Brazil
hcfmusp.author.externalHANSEN, Aaron:Princess Margaret Canc Ctr, Deparment Med Oncol, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada
hcfmusp.author.externalSALAH, Samer:King Hussein Canc Ctr, Med Oncol Dept, Amman, Jordan
hcfmusp.description.beginpage76
hcfmusp.description.endpage84
hcfmusp.description.volume135
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000461262800010
hcfmusp.origem.id2-s2.0-85061114948
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAbdollah F, 2012, BJU INT, V109, P564, DOI 10.1111/j.1464-410X.2011.10357.xeng
hcfmusp.relation.referenceAbdulamir AS, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-27eng
hcfmusp.relation.referenceAbol-Enein H, 2007, UROLOGY, V69, P93, DOI 10.1016/j.urology.2006.08.1107eng
hcfmusp.relation.referenceAntoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010eng
hcfmusp.relation.referenceApolo AB, 2017, J CLIN ONCOL, V35, P2117, DOI 10.1200/JCO.2016.71.6795eng
hcfmusp.relation.referenceAragon-Ching Jeanny B, 2018, J CLIN ONCOL S6S, V36eng
hcfmusp.relation.referenceBadr KM, 2004, HUM PATHOL, V35, P184, DOI 10.1016/j.humpath.2003.10.006eng
hcfmusp.relation.referenceBalar A, 2016, ANN ONCOL, V27, DOI [10.1093/annonc/mdw435.25.LBA32_PR-LBA32_PR, DOI 10.1093/ANNONC/MDW435.25.LBA32_PR-LBA32_PR]eng
hcfmusp.relation.referenceBalar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2eng
hcfmusp.relation.referenceBALAR AV, 2018, J CLIN ONCOL S, V36eng
hcfmusp.relation.referenceBaldia PH, 2016, ONCOTARGET, V7, P71429, DOI 10.18632/oncotarget.12198eng
hcfmusp.relation.referenceBellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683eng
hcfmusp.relation.referenceBlaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409eng
hcfmusp.relation.referenceBrahmer J, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1504627.150531143008000-150531143008000, DOI 10.1056/NEJMOA1504627.150531143008000-150531143008000]eng
hcfmusp.relation.referenceCelis JE, 2000, ELECTROPHORESIS, V21, P2115eng
hcfmusp.relation.referenceChalasani Venu, 2009, Can Urol Assoc J, V3, pS193eng
hcfmusp.relation.referenceChoi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129eng
hcfmusp.relation.referenceChoi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009eng
hcfmusp.relation.referenceDahm P, 2003, EUR UROL, V44, P672, DOI 10.1016/S0302-2838(03)00416-0eng
hcfmusp.relation.referenceDamrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111eng
hcfmusp.relation.referenceEissa S, 2005, CLIN BIOCHEM, V38, P142, DOI 10.1016/j.clinbiochem.2004.09.004eng
hcfmusp.relation.referenceEl-Kenawy AE, 2006, INT J BIOL MARKER, V21, P170eng
hcfmusp.relation.referenceEL-Kenawy AE, 2003, INT J BIOL MARKER, V18, P284eng
hcfmusp.relation.referenceEl-Rifai W, 2000, AM J PATHOL, V156, P871, DOI 10.1016/S0002-9440(10)64956-5eng
hcfmusp.relation.referenceFelix AS, 2008, CANCER CAUSE CONTROL, V19, P421, DOI 10.1007/s10552-007-9104-7eng
hcfmusp.relation.referenceFerris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252eng
hcfmusp.relation.referenceFradet Y, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4521eng
hcfmusp.relation.referenceGallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1eng
hcfmusp.relation.referenceGalsky MD, 2007, UROLOGY, V69, P255, DOI 10.1016/j.urology.2006.10.029eng
hcfmusp.relation.referenceGHONEIM MA, 1985, J UROLOGY, V134, P266, DOI 10.1016/S0022-5347(17)47119-9eng
hcfmusp.relation.referenceGhoneim MA, 1997, J UROLOGY, V158, P393, DOI 10.1016/S0022-5347(01)64487-2eng
hcfmusp.relation.referenceGuo CC, 2009, HUM PATHOL, V40, P1448, DOI 10.1016/j.humpath.2009.03.005eng
hcfmusp.relation.referenceHaitel A, 2001, J UROLOGY, V165, P1481, DOI 10.1016/S0022-5347(05)66332-Xeng
hcfmusp.relation.referenceHammam O, 2015, ARAB J UROL, V13, P146, DOI 10.1016/j.aju.2015.01.004eng
hcfmusp.relation.referenceHammam Olfat, 2014, J Egypt Soc Parasitol, V44, P733eng
hcfmusp.relation.referenceHigano CS, 2008, CANCER-AM CANCER SOC, V112, P2181, DOI 10.1002/cncr.23420eng
hcfmusp.relation.referenceHirasawa E, 2002, J UROLOGY, V167, P2130, DOI 10.1016/S0022-5347(05)65104-Xeng
hcfmusp.relation.referenceHussain M, 2001, J CLIN ONCOL, V19, P2527, DOI 10.1200/JCO.2001.19.9.2527eng
hcfmusp.relation.referenceIyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344eng
hcfmusp.relation.referenceJames ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106eng
hcfmusp.relation.referenceJemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]eng
hcfmusp.relation.referenceKassouf W, 2007, CANCER, V110, P764, DOI 10.1002/cncr.22853eng
hcfmusp.relation.referenceKastritis E, 2006, ANTICANCER RES, V26, P3865eng
hcfmusp.relation.referenceKhaled HM, 2000, EUR J CANCER, V36, pS34, DOI 10.1016/S0959-8049(00)00079-4eng
hcfmusp.relation.referenceKijima T, 2018, J CLIN ONCOL S6S, V36eng
hcfmusp.relation.referenceKwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5eng
hcfmusp.relation.referenceLagwinski N, 2007, AM J SURG PATHOL, V31, P1777, DOI 10.1097/PAS.0b013e31805c9cd9eng
hcfmusp.relation.referenceLe DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596eng
hcfmusp.relation.referenceLOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9eng
hcfmusp.relation.referenceMakboul R, 2015, KOREAN J UROL, V56, P31, DOI 10.4111/kju.2015.56.1.31eng
hcfmusp.relation.referenceManunta A, 2005, BJU INT, V95, P497, DOI 10.1111/j.1464-410X.2005.05327.xeng
hcfmusp.relation.referenceMartin JW, 2016, ARAB J UROL, V14, P183, DOI 10.1016/j.aju.2016.07.001eng
hcfmusp.relation.referenceMcNiel EA, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.45eng
hcfmusp.relation.referenceMilowsky MI, 2014, EUR J CANCER, V50, P3145, DOI 10.1016/j.ejca.2014.10.013eng
hcfmusp.relation.referenceMilowsky MI, 2013, BJU INT, V112, P462, DOI 10.1111/j.1464-410X.2012.11720.xeng
hcfmusp.relation.referenceMolitor M, 2015, INT J CLIN EXP PATHO, V8, P8143eng
hcfmusp.relation.referenceMotzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665eng
hcfmusp.relation.referenceNogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048eng
hcfmusp.relation.referenceOing C, 2016, J UROLOGY, V195, P254, DOI 10.1016/j.juro.2015.06.115eng
hcfmusp.relation.referenceOmran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20eng
hcfmusp.relation.referenceOstergaard M, 1999, ELECTROPHORESIS, V20, P349eng
hcfmusp.relation.referencePal SK, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4517eng
hcfmusp.relation.referencePannek J, 2002, UROLOGY, V59, P240, DOI 10.1016/S0090-4295(01)01495-9eng
hcfmusp.relation.referencePorter MP, 2002, J UROLOGY, V168, P1960, DOI 10.1097/01.ju.0000034384.91899.67eng
hcfmusp.relation.referencePowles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-Xeng
hcfmusp.relation.referencePowles T, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2411eng
hcfmusp.relation.referencePowles T, 2017, J CLIN ONCOL, V35, P48, DOI 10.1200/JCO.2015.66.3468eng
hcfmusp.relation.referencePREMPREE T, 1984, ACTA RADIOL ONCOL, V23, P37, DOI 10.3109/02841868409135983eng
hcfmusp.relation.referencePycha A, 1999, UROLOGY, V53, P1005, DOI 10.1016/S0090-4295(98)00626-8eng
hcfmusp.relation.referenceRAMCHURREN N, 1995, INT J CANCER, V62, P237, DOI 10.1002/ijc.2910620302eng
hcfmusp.relation.referenceRosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4eng
hcfmusp.relation.referenceShaker OG, 2013, BIOMED PHARMACOTHER, V67, P183, DOI 10.1016/j.biopha.2012.10.019eng
hcfmusp.relation.referenceSharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7eng
hcfmusp.relation.referenceShokeir AA, 2004, BJU INT, V93, P216, DOI 10.1046/j.1464-410X.2004.04588.xeng
hcfmusp.relation.referenceSlim M, 2018, J CLIN ONCOL S6S, V36eng
hcfmusp.relation.referenceSoria JC, 2016, ANN ONCOL, V27, P2268, DOI 10.1093/annonc/mdw427eng
hcfmusp.relation.referenceSpradling K, 2016, UROL ONCOL, V34, pe411, DOI 10.1016/j.urolonc.2016.03.023eng
hcfmusp.relation.referenceSTEIN JP, 1993, J UROLOGY, V149, P588, DOI 10.1016/S0022-5347(17)36156-6eng
hcfmusp.relation.referenceSubbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911eng
hcfmusp.relation.referenceSWANSON DA, 1990, J UROLOGY, V143, P37, DOI 10.1016/S0022-5347(17)39857-9eng
hcfmusp.relation.referenceVaidyanathan Subramanian, 2002, BMC Urol, V2, P8, DOI 10.1186/1471-2490-2-8eng
hcfmusp.relation.referenceWagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353eng
hcfmusp.relation.referenceWeinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965eng
hcfmusp.relation.referenceWelk B, 2013, SPINAL CORD, V51, P516, DOI 10.1038/sc.2013.33eng
hcfmusp.relation.referenceWestenend PJ, 2001, BJU INT, V88, P198, DOI 10.1046/j.1464-410x.2001.02230.xeng
hcfmusp.relation.referenceWysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431eng
hcfmusp.relation.referenceYoussef R, 2011, BJU INT, V108, P31, DOI 10.1111/j.1464-410X.2010.09854.xeng
hcfmusp.relation.referenceYoussef RF, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.020eng
hcfmusp.relation.referenceYoussef RF, 2015, J UROLOGY, V193, P451, DOI 10.1016/j.juro.2014.08.109eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1879-0461
hcfmusp.citation.scopus9-
hcfmusp.scopus.lastupdate2024-02-23-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MAIA_Biomarkers_in_NonSchistosomiasisrelated_squamous_cell_carcinoma_of_the_2019.PDF
  Restricted Access
publishedVersion (English)287.65 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.